Biogen is absorbing a $164M charge in Q2 and forecasts another $290M-$320M in Q3 for R&D deals, significantly impacting profitability. This sustained hit to earnings creates urgent pressure on finance and operations to optimize costs and improve financial forecasting.
Filing excerpt
Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kmarginPressureGet every 8-K signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/812cdbc5-21f3-49f6-945b-67324e3c7d77 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "812cdbc5-21f3-49f6-945b-67324e3c7d77",
"signal_type": "sec-8k",
"signal_subtype": "marginPressure",
"detected_at": "2026-07-07T07:06:39.962+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen is absorbing a $164M charge in Q2 and forecasts another $290M-$320M in Q3 for R&D deals, significantly impacting profitability. This sustained hit to earnings creates urgent pressure on finance and operations to optimize costs and improve financial forecasting.",
"metrics": {
"timeframe": "next_quarter",
"dollar_context": "Total expected R&D-related charges against earnings for Q2 and Q3 2026 (using $164M for Q2 and high-end $320M for Q3).",
"dollar_millions": 484
},
"summary": "Biogen flags up to $484M in R&D charges, pressuring Q2 & Q3 earnings.",
"excerpts": "Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000068/biib-20260701.htm",
"filing_date": "2026-07-01",
"filing_year": 2026,
"fiscal_year_end": "07/01",
"sales_relevance": "Efficiency tools needed",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/812cdbc5-21f3-49f6-945b-67324e3c7d77 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.